Venta de servicios médicos

Caja Costarricense de Seguro Social.
Rev. jurid. segur. soc ; (5): 43-55, oct. 1994.
Artigo em Espanhol | LILACS | ID: lil-176418

Documentos relacionados

  1. Problematic Promotion of Medications by Nurse Ambassadors-Legal and Ethical Issues.
  2. Stem cell clinics: risk of proliferation.
  3. The FDA's Experience with Covid-19 Antibody Tests.
  4. In the Supreme Court of the United States Docket No. 18-102.
  5. [Direct-to-consumer genetic testing: a regulation by the market, or a medical regulation?]
  6. Marketing of healthcare services in Denmark: the concept of misleading advertising.
  7. New modalities of prescription of ATUns: Evolutions and revolution.
  8. Rogue stem cell clinics.
  9. Truth-in-Advertising Laws: Are They Working? A Cross-Sectional Analysis of a "Plastic Surgeon" Patient Search Simulation.
  10. The direct-to-consumer market for stem cell-based interventions in Australia: exploring the experiences of patients.